CRIS
CURIS INC
$0.4200
-2.33%
$16.4M
No data for this timeframe.
Vol
Market Cap$16.4M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders15 funds
Inst. Value$676.8K
Inst. Activity2 buys / 0 sells
Insider Activity1B / 0S
Insider Net $$5.5K
SEC Reports4
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001108205·Prev Close $0.4300
Recent Activity
May 22, 2026
SEC
Curis Inc. shareholders approved a charter amendment at the May 19, 2026 annual meeting to nearly double authorized comm
8-K — Impact 6/10
May 12, 2026
SEC
Curis reported Q1 2026 results with zero revenue (post-Erivedge sale) and a net loss of $24.2M, significantly worse than
8-K — Impact 7/10
May 1, 2026
SEC
Curis received a Nasdaq delisting determination letter on April 27, 2026, because its common stock bid price closed belo
8-K — Impact 8/10
Mar 31, 2026
Insider
KAITIN KENNETH I bought 10,000 shares
Director @ $0.5487 ($5.5K)
Mar 20, 2026
Insider
Zung Jonathan B. disposed of 50 shares
CDO
Mar 20, 2026
Insider
Duvall Diantha acquired 66,666 shares
CFO
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
366,740 shares ($200.7K)
Inst.
MORGAN STANLEY — DOUBLED
254,245 shares ($139.1K)
Price Targets
$14.00
+3224.6% upside
Strong Buy
Current $0.4211
Low $5.00
Median $17.00
High $20.00
3 analysts
$5.00
$20.00
Analyst Ratings
2Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 20, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.35 | $-0.53 — $-0.22 | 49% YoY | 3 |
| Next Q | $-0.34 | $-0.52 — $-0.20 | 31% YoY | 3 |
| Current FY | $-1.56 | $-2.61 — $-0.91 | 41% YoY | 3 |
| Next FY | $-1.19 | $-2.66 — $-0.24 | 24% YoY | 3 |
Latest Reports
BEARISH
8-K
6/10
Curis Inc. shareholders approved a charter amendment at the May 19, 2026 annual meeting to nearly double authorized comm
May 22, 2026
BEARISH
8-K
7/10
Curis reported Q1 2026 results with zero revenue (post-Erivedge sale) and a net loss of $24.2M, significantly worse than
May 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $204.8K | — |
| RENAISSANCE TECHNOLOGIES LLC | $200.7K | ADD |
| MORGAN STANLEY | $139.1K | DOUBLED |
| CITADEL ADVISORS LLC | $36.7K | — |
| VANGUARD FIDUCIARY TRUST CO | $33.7K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 31, 2026 | KAITIN KENNETH | BUY | $5.5K |
| Mar 20, 2026 | Zung Jonathan | C | $0.00 |
| Mar 20, 2026 | Duvall Diantha | C | $0.00 |
| Mar 20, 2026 | Dentzer James | C | $0.00 |
| Mar 20, 2026 | Rubin Marc | C | $0.00 |
15 institutional holders with $676.8K total value (1,265,172 shares) as of 2026-Q1. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 374,326 | $204.8K | 30.3% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 366,740 | $200.7K | 29.7% | ADD +52.2% |
| 3 | MORGAN STANLEY | 254,245 | $139.1K | 20.6% | DOUBLED +445943.9% |
| 4 | CITADEL ADVISORS LLC | 67,018 | $36.7K | 5.4% | — |
| 5 | VANGUARD FIDUCIARY TRUST CO | 61,664 | $33.7K | 5.0% | — |
| 6 | BlackRock, Inc. | 53,484 | $29.3K | 4.3% | — |
| 7 | PRUDENTIAL FINANCIAL INC | 35,400 | $19.4K | 2.9% | — |
| 8 | STATE STREET CORP | 21,049 | $11.5K | 1.7% | — |
| 9 | Vanguard Global Advisers, LLC | 1,541 | $843.00 | 0.1% | — |
| 10 | ASSETMARK, INC | 700 | $383.00 | 0.1% | — |
| 11 | GROUP ONE TRADING LLC | 450 | $246.00 | 0.0% | TRIM -50.8% |
| 12 | JONES FINANCIAL COMPANIES LLLP | 120 | $67.00 | 0.0% | — |
| 13 | WELLS FARGO & COMPANY/MN | 55 | $30.00 | 0.0% | DOUBLED +133.3% |
| 14 | CWM, LLC | 51 | $28.00 | 0.0% | — |
| 15 | HRT FINANCIAL LP | 28,329 | $15.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | 240,917 | 366,740 | +52.2% | $200.7K | 2026-Q1 |
| MORGAN STANLEY | DOUBLED | 57 | 254,245 | +445943.9% | $139.1K | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 175,513 | 240,917 | +37.3% | $237.8K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 211 | 118 | -44.1% | $117.00 | 2025-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 845 | 57 | -93.3% | $56.00 | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 100,472 | 175,513 | +74.7% | $291.4K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 1,717 | 402 | -76.6% | $667.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 102 | 211 | +106.9% | $350.00 | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 15 | 35 | +133.3% | $58.00 | 2025-Q3 |
| ROYAL BANK OF CANADA | DOUBLED | 457 | 3,328 | +628.2% | $7.0K | 2025-Q2 |
| UBS Group AG | DOUBLED | 388 | 1,717 | +342.5% | $4.0K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 8 | 15 | +87.5% | $35.00 | 2025-Q2 |
| ROYAL BANK OF CANADA | NEAR_EXIT | 2,875 | 457 | -84.1% | — | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 310 | 8 | -97.4% | $17.00 | 2025-Q1 |
| ROYAL BANK OF CANADA | DOUBLED | 801 | 2,875 | +258.9% | $8.0K | 2024-Q4 |
| UBS Group AG | DOUBLED | 42 | 399 | +850.0% | $1.2K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 54 | 72 | +33.3% | $220.00 | 2024-Q4 |
| ROYAL BANK OF CANADA | TRIM | 1,235 | 801 | -35.1% | $5.0K | 2024-Q3 |
| GROUP ONE TRADING LLC | TRIM | 914 | 450 | -50.8% | $2.4K | 2024-Q3 |
6 unique insiders with 31 transactions. Net insider value: $5.5K ($5.5K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | KAITIN KENNETH I | Director | BUY | 10,000 | $0.5487 | $5.5K |
| Mar 20, 2026 | Zung Jonathan B. | CDO | CONVERT | 50 | — | — |
| Mar 20, 2026 | Duvall Diantha | CFO | CONVERT | 66,666 | — | — |
| Mar 20, 2026 | Dentzer James E | President & CEO | CONVERT | 133,333 | — | — |
| Mar 20, 2026 | Rubin Marc | Director | CONVERT | 26,667 | — | — |
| Mar 20, 2026 | Duvall Diantha | CFO | CONVERT | 50 | — | — |
| Mar 20, 2026 | Rubin Marc | Director | CONVERT | 20 | — | — |
| Mar 20, 2026 | Hamdy Ahmed MD | CMO | CONVERT | 66,667 | — | — |
| Mar 20, 2026 | Dentzer James E | President & CEO | CONVERT | 100 | — | — |
| Mar 20, 2026 | Hamdy Ahmed MD | CMO | CONVERT | 50 | — | — |
| Mar 20, 2026 | Zung Jonathan B. | CDO | CONVERT | 66,667 | — | — |
| Mar 17, 2026 | Zung Jonathan B. | CDO | AWARD | 66,667 | — | — |
| Mar 17, 2026 | Duvall Diantha | CFO | AWARD | 66,666 | — | — |
| Mar 17, 2026 | Duvall Diantha | CFO | AWARD | 50 | — | — |
| Mar 17, 2026 | Dentzer James E | President & CEO | AWARD | 133,333 | — | — |
| Mar 17, 2026 | Dentzer James E | President & CEO | AWARD | 133,333 | — | — |
| Mar 17, 2026 | Rubin Marc | Director | AWARD | 26,667 | — | — |
| Mar 17, 2026 | Hamdy Ahmed MD | CMO | AWARD | 66,667 | — | — |
| Mar 17, 2026 | Zung Jonathan B. | CDO | AWARD | 50 | — | — |
| Mar 17, 2026 | Duvall Diantha | CFO | AWARD | 66,666 | — | — |
| Mar 17, 2026 | Hamdy Ahmed MD | CMO | AWARD | 66,667 | — | — |
| Mar 17, 2026 | Rubin Marc | Director | AWARD | 26,667 | — | — |
| Mar 17, 2026 | Dentzer James E | President & CEO | AWARD | 100 | — | — |
| Mar 17, 2026 | Hamdy Ahmed MD | CMO | AWARD | 50 | — | — |
| Mar 17, 2026 | Rubin Marc | Director | AWARD | 20 | — | — |
| Mar 17, 2026 | Rubin Marc | Director | AWARD | 26,667 | — | — |
| Mar 17, 2026 | Dentzer James E | President & CEO | AWARD | 133,333 | — | — |
| Mar 17, 2026 | Duvall Diantha | CFO | AWARD | 66,666 | — | — |
| Mar 17, 2026 | Zung Jonathan B. | CDO | AWARD | 66,667 | — | — |
| Mar 17, 2026 | Hamdy Ahmed MD | CMO | AWARD | 66,667 | — | — |
| Mar 17, 2026 | Zung Jonathan B. | CDO | AWARD | 66,667 | — | — |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 1 neutral. Avg impact: 6.3/10.
BEARISH
8-K
6/10
Curis Inc. shareholders approved a charter amendment at the May 19, 2026 annual meeting to nearly do
May 22, 2026
BEARISH
8-K
7/10
Curis reported Q1 2026 results with zero revenue (post-Erivedge sale) and a net loss of $24.2M, sign
May 12, 2026
BEARISH
8-K
8/10
Curis received a Nasdaq delisting determination letter on April 27, 2026, because its common stock b
May 1, 2026
NEUTRAL
EFFECT
4/10
Curis Inc. (CRIS) has had a registration statement on Form S-3 become effective, allowing the compan
Mar 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (90% buy). Based on 10 analysts: 2 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$14.00 mean target
+3224.6% upside
Strong Buy (3.00)
$5.00 Low
$20.00 High
| Metric | Value |
|---|---|
| Current Price | $0.4211 |
| Target Low | $5.00 |
| Target Mean | $14.00 |
| Target Median | $17.00 |
| Target High | $20.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.35 | $-0.53 | $-0.22 | 49.0% | — | 0↑ 1↓ | $0.0B | -72.7% | 3 |
| Next Q 2026-09-30 |
$-0.34 | $-0.52 | $-0.20 | 31.3% | — | 0↑ 1↓ | $0.0B | -76.4% | 3 |
| Current FY 2026-12-31 |
$-1.56 | $-2.61 | $-0.91 | 40.9% | — | — | $0.0B | -81.5% | 3 |
| Next FY 2027-12-31 |
$-1.19 | $-2.66 | $-0.24 | 23.9% | — | — | $0.0B | 628.6% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.347 | |
| 7d ago | $0.000 | -0.347 |
| 30d ago | $0.000 | -0.347 |
| 60d ago | $-0.310 | -0.037 |
| 90d ago | $-0.310 | -0.037 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 20, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| May 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Apr 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| Mar 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 4, 2026
earnings_calendar
CRIS Q1 2026 Earnings Scheduled — 2026-05-04
Mar 30, 2026
earnings_calendar
CRIS Q4 2025 Earnings After Market Close — 2026-03-30